Priority Digital Health appoints Josh Meadows as Head of Commercial
Leading digital health company Priority Digital Health welcomes former BSi and Trustpilot talent Josh Meadows as Head of Commercial.
Thinking about downsizing your office space? Read this first.
HR Dept says: cost saving may be a motivator when downsizing your office space, but before you start offloading furniture, there are a few things to think about. Read more in our latest blog.
Closed Loop Medicine appoints David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer
London, UK - Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that enable personalised dose optimisation, announces it has appointed David Van Sickle PhD as Non-Executive Director and Simon Ramsden as Chief Financial Officer.
FUJIFILM Irvine Scientific Launches Heavy Oil for Embryo Culture: Optimized Protection for the IVF Laboratory
SANTA ANA, Calif., FUJIFILM Irvine Scientific, Inc., a world leader in the innovation, development, and manufacture of cell culture media and assisted reproductive technologies (ART), announces the launch of its Heavy Oil for Embryo Culture, a sterile mineral oil with an optimal weight viscosity that provides the ideal balance between ease of use and protection.
Are you more adaptable than you think?
High Performance Change says: last week, we Brits found out what everyone south of Dover has known since glass was invented: when it gets hot, don’t open your windows, close them. Well, it was news to me, as I guess it was to most Brits given that it was on the news.
Celebrating 20 years of Pure
In 2002 Ian, Gill and Caroline started a recruitment consultancy with a difference, from a tiny room in Cambridge.
New informatics suite to guide formulations decisions with a deep understanding of particle behaviour
New informatics software from the Cambridge Crystallographic Data Centre draws on data from 1.1M validated and published crystal structures to guide formulations decisions with a deep understanding of particle behaviour. Software will transform pharmaceutical and fine chemical manufacturing by anticipating and eliminating potential bottlenecks with the new CSD-Particle Suite.
Timestrip introduces new indicator technology
Timestrip® has developed a completely new electronic indicator technology capable of highly versatile operation at low cost. The Timestrip neo is a platform for a series of single use electronic temperature indicators suitable for pack level monitoring with both time and multiple temperature settings.
Why we need user insights in digital product design
When designing a digital medical device, it is essential to understand what your users will expect from your product and how it will fit into their everyday routines. In a new article for International Pharmaceutical Industry (IPI), Charlotte Harris, Head of Front End Innovation, explores several research techniques to gather rich user insights for your digital product design.
Mondana Cook joins PBD Biotech to bring human TB diagnostic to market
New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine to progress Actiphage diagnosis to meet the global TB challenge.
CN Bio opens new laboratory facilities to extend Organ-on-a-chip contract research services capabilities
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for Organ-on-a-Chip research services
Summer update – Guardtech continue to shine as brilliant builds mount up
The Group have enjoyed a super-busy start to 2022 – and there’s still a lot more to come
Sensors in Medicine 2022 Program - engage with Captum Capital
Clinical diagnostic medicine and healthcare monitoring are arguably the most important applications of biosensor technology. The Covid-19 pandemic has demonstrated both the need for advanced diagnostic sensors as well as the capability of research groups around the world to respond rapidly to this unprecedented need. The 10th Annual Sensors in Medicine 2022 conference will highlight the newest…
Diversity – the human factor
A member of Team Consulting says: in June 2022, UK’s Sheffield Hallam University announced it was closing its English Literature degree course. A debate followed in the press over the value of humanities degrees. I was glad to see many people echoing the thoughts I’ve had about the value of an English degree. It made me, in turn, reflect on the value of diversity in a consultancy like Team…
FUJIFILM Irvine Scientific Opens New Armstrong R&D Cell Culture Center of Excellence
SANTA ANA, California, FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has announced the completion of its Armstrong Cell Culture Center of Excellence. More than doubling the R&D facility’s footprint, the new state-of-the-art center enables the Company to…
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Bioanalysis and Drug Monitoring
Hercules, Calif - Bio-Rad Laboratories, Inc, a global leader in life science research and clinical diagnostic products, extends its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to brentuximab vedotin (Adcetris), secukinumab (Cosentyx), and the secukinumab–interleukin 17A (IL-17A) drug-target complex. These sequence-defined antibodies are…
Centauri Therapeutics strengthens senior leadership team with three key appointments
Centauri Therapeutics Limited (Centauri), an immunotherapy company focused on the treatment of infectious diseases, today announced three senior appointments: Dr Jennifer Schneider as Chief Executive Officer (CEO), Dr Helen Bright as Vice President (VP) of Research & Development (R&D), and Professor David Roblin FRCP FMedSci as Chair of the Board of Directors.
Anthias Consulting courses at heart of analytical chemistry training in Africa
In June 2022, Anthias Consulting's training course materials were used to deliver a week-long practical based LC-MS workshop at the Kwame Nkrumah University of Science and Technology (KNUST) in Ghana.
Breakfast or Hotel Bar?
WaveFX says: So, after two years adapting to virtual and hybrid events from the studio and breakfast bar we’re happily back on the road. This week the WaveFX stream team produced and filmed webcasts and live events from conference hotels and venues across the UK, Sweden and Greece.
5 things every electrical medical device start-up should know
You’ve got a great idea for an electrical medical device, whether that’s a connected injector, point of care diagnostics device, a wearable device, or another innovative, life-changing device concept. You’ve identified a market for it, gained access to sector insights, you’ve tested the principles and are getting good results. All you need now is to engineer it into a real medical device product…
What you need to know when hiring workers from abroad
Has recruitment for your business got you thinking about hiring workers from overseas? There are a few things you need to know to ensure you remain compliant with employment law. We explore this topic further in our latest blog.
Hospital’s green bus service is just the ticket for patients and planet
Cambridge University Hospitals (CUH) has launched an environmentally friendly patient courtesy bus service, thanks to a team effort by ACT and a well-known patient governor.
Charity’s first Newmarket Race Day raises more than £40,000 to fund a psychologist for children with brain tumours
A children’s charity’s first ever race day at Newmarket Racecourse has raised more than £40,000 to fund a psychologist for families faced with a brain tumour.
Ubiquigent appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
Experts in structural biology and drug development will help exploit the deubiquitylase (DUB) enzyme family as new drug targets
Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss
Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, and Astellas Pharma Inc., a leader in regenerative medicine, today announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.